Pharmaceutical

AAIC 2024: the evolution of Alzheimer’s clinical trials

Clinical trial trends point to studying combination therapies and lifestyle changes using alternate designs in Alzheimer’s research.

Jul 30, 2024 - 04:00
AAIC 2024: the evolution of Alzheimer’s clinical trials
Clinical trial trends point to studying combination therapies and lifestyle changes using alternate designs in Alzheimer’s research.
Read the original article

Tags:

Previous Article

Bold moves needed for California agriculture to adapt to climate change

Next Article

CHMP backs Boehringer’s Spevigo for preventing rare psoriasis flare-ups

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: At Orexo, a ‘turning point’ for everything but digital health

STAT+: At Orexo, a ‘turning point’ for everything but d...

Jul 18, 2023

STAT+: Pharmalittle: Judge blocks required ACA coverage for preventive care; Supreme Court urged to review skinny label case

STAT+: Pharmalittle: Judge blocks required ACA coverage...

Apr 1, 2023

Listen: SVB’s long biotech shadow, pushy AI algorithms, & Icahn v. Illumina

Listen: SVB’s long biotech shadow, pushy AI algorithms,...

Mar 19, 2023